1. Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
   Ilaria Girolami et al, 2023, Journal of Personalized Medicine CrossRef
2. Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
   Stefano Marletta et al, 2022, Journal of Personalized Medicine CrossRef
3. Recurrent Oropharyngeal Squamous Cell Carcinomas Maintain Anti-tumor Immunity and Multinucleation Levels Following Completion of Radiation
   Patricia Castro et al, 2023, Head and Neck Pathology CrossRef
4. Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study
   Ruey-Long Hong et al, 2024, Oral Oncology CrossRef
5. Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
   Elena Guerini Rocco et al, 2022, Diagnostics CrossRef
6. PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy
   Gaetano Paolino et al, 2021, Pathology - Research and Practice CrossRef
7. Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study
   Bruna Cerbelli et al, 2022, Histopathology CrossRef